Hessheimer, Amelia JColl, ElisabethRuíz, PatriciaGastaca, MikelRivas, Jose IgnacioGomez, ManuelSanchez, BelindaSantoyo, JulioRamirez, PabloParrilla, PascualMarin, Luis MiguelGomez-Bravo, Miguel AngelGarcia-Valdecasas, Juan CarlosLopez-Monclus, JavierBosca, AndreaLopez-Andujar, RafaelFundora-Suarez, YiliamVillar, JesusGarcia-Sesma, AlvaroJimenez, CarlosRodríguez-Laiz, GonzaloLlado, LauraRodriguez, Juan CarlosBarrera, ManuelCharco, RamonLopez-Baena, Jose AngelBriceño, JavierPardo, FernandoBlanco, GerardoPacheco, DavidDominguez-Gil, BeatrizSanchez Turrion, VictorFondevila, Constantino2023-01-252023-01-252019-05-23Hessheimer AJ, Coll E, Ruíz P, Gastaca M, Rivas JI, Gómez M, et al. Reply to: "Normothermic regional perfusion - What is the benefit?". J Hepatol. 2019 Aug;71(2):443-445http://hdl.handle.net/10668/14024Wethank Drs. Schlegel, Muiesan, and Dutkowski for their interest in our manuscript1 and are delighted to provide clearer and updated information regarding the use of normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation. Our manuscript describes the Spanish experience with cDCD liver transplantation from national application in 2012 through 2016, comparing outcomes of transplants performed with NRP versus those performed with super rapid recovery (SRR).2 Transplants were included from 20 centers, only 3 (15%) with previous experience performing uncontrolled donation after circulatory death. The results that we present can be achieved by not just perfusion and DCD ‘‘experts” but by virtually any liver transplant team.enLiver TransplantationPerfusionTissue and Organ ProcurementDeathHumansLiver TransplantationOrgan PreservationPerfusionresearch article31130439Restricted AccessTrasplante de hígadoMuertePerfusiónTrasplantesTrasplante de riñón10.1016/j.jhep.2019.04.0051600-0641http://www.journal-of-hepatology.eu/article/S0168827819302661/pdf